Literature DB >> 18278685

Factors affecting morbidity in chronic tuberculous empyema.

Y Sonmezoglu1, A Turna, A Cevik, A Demir, A Sayar, Y Dincer, M A Bedirhan, A Gurses.   

Abstract

BACKGROUND: Chronic empyema is not a rare complication of pulmonary tuberculosis. Various treatment modalities ranging from open drainage to pneumonectomy, depending on the status of the disease, have been used to treat this complication. However, the best strategy for this disease remains unknown. This study examined the results of different treatment strategies for chronic tuberculous empyema.
METHODS: Between January 1993 and December 2002, 36 patients (29 male and 7 female) with an average age of 29.3 years (range 13 - 52 years) presented with chronic tuberculous empyema characterized by empyema cavity and persistent pleural infections that were secondary to tuberculosis. The series consisted of patients who had had tube thoracostomy and underwater drainage without complete re-expansion. All patients were treated with open drainage. Of these, 6 patients had Eloesser flap for complete drainage of pleural pus and resolution of pleural infection.
RESULTS: Eloesser-flap drainage resulted in a higher morbidity compared to the open-drainage-only method ( P = 0.011). Pneumonectomy, used as a final therapeutic option, resulted in more complications postoperatively ( P = 0.034). Antituberculosis therapy lasting six months or longer reduced the morbidity rate (54 % vs. 33.3 %), but the difference was not significant.
CONCLUSIONS: Our findings indicate that open drainage leads to better results compared to those of Eloesser flap in patients with chronic tuberculous empyema. Patients who underwent pneumonectomy were expected to have higher complication rates and the procedure must therefore be avoided when possible.

Entities:  

Mesh:

Year:  2008        PMID: 18278685     DOI: 10.1055/s-2007-965301

Source DB:  PubMed          Journal:  Thorac Cardiovasc Surg        ISSN: 0171-6425            Impact factor:   1.827


  5 in total

Review 1.  Tuberculous pleural effusions: advances and controversies.

Authors:  Morné J Vorster; Brian W Allwood; Andreas H Diacon; Coenraad F N Koegelenberg
Journal:  J Thorac Dis       Date:  2015-06       Impact factor: 2.895

2.  Pleural tuberculosis: a key differential diagnosis for pleural thickening, even without obvious risk factors for tuberculosis in a low incidence setting.

Authors:  Keir Elmslie James Philip; Onn Min Kon; Mary Roddie; Clare Ross
Journal:  BMJ Case Rep       Date:  2018-10-27

3.  Outcomes of Video-Assisted Thoracic Surgical Decortication in 274 Patients with Tuberculous Empyema.

Authors:  Baofu Chen; Jian Zhang; Zhongrui Ye; Minhua Ye; Dehua Ma; Chunguo Wang; Chengchu Zhu
Journal:  Ann Thorac Cardiovasc Surg       Date:  2015-03-27       Impact factor: 1.520

4.  Performance of TB-LAMP in the Diagnosis of Tuberculous Empyema Using Samples Obtained From Pleural Decortication.

Authors:  Chang Liu; Lichao Fan; Jiansong Zhang; Qi Hong; Yi Ren; Huaiyu Tian; Yu Chen
Journal:  Front Med (Lausanne)       Date:  2022-06-29

5.  IgA and IgG antibody detection of mycobacterial antigens in pleural fluid and serum from pleural tuberculous patients.

Authors:  Renan Jeremias da Silva; Raquel da Silva Corrêa; Isabela Gama Sardella; Ana Carla de Paulo Mulinari; Thiago Thomaz Mafort; Ana Paula Santos; Rogério Rufino; Luciana Silva Rodrigues; Maria Helena Féres Saad
Journal:  BMC Immunol       Date:  2019-10-17       Impact factor: 3.615

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.